TMFCX | VMVAX | TMFCX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 13 years | - |
Gain YTD | 12.361 | 17.355 | 71% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 629M | 30.9B | 2% |
Annual Yield % from dividends | 0.70 | 2.14 | 33% |
Returns for 1 year | 20.85 | 27.09 | 77% |
Returns for 3 years | -4.92 | 13.54 | -36% |
Returns for 5 years | 29.18 | 47.45 | 61% |
Returns for 10 years | 37.43 | 96.84 | 39% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DRLYX | 8.58 | 0.01 | +0.12% |
BNY Mellon Developed Markets RE Scs - Y | |||
TNYRX | 10.92 | -0.02 | -0.17% |
1290 Loomis Sayles Multi-Asset Income R | |||
GAOZX | 20.56 | -0.15 | -0.72% |
JPMorgan Global Allocation R6 | |||
MWOIX | 67.59 | -0.83 | -1.21% |
MFS Global Growth I | |||
APGYX | 114.42 | -3.12 | -2.65% |
AB Large Cap Growth Advisor |